Biopsy Devices Market Analysis

Biopsy Devices Market Analysis

Biopsy devices market value from the biopsy forceps is set to surpass USD 170 million by 2032, on account of the surge in cases of skin disorders including eczema. Furthermore, there has been an increase in the number of biopsy procedures among patients with skin disorders. These factors, alongside the introduction of superior products for convenient and rapid sample collection, will stimulate the use of equipment such as biopsy forceps.
 

Biopsy devices market from ambulatory surgery center is expected to exhibit a CAGR of over 7.5% between 2023 and 2032 due to the affordability and range of healthcare services provided through ASCs. According to data from the Centers for Medicare & Medicaid Services, the number of these surgical centers is increasing by an average of 1.7% annually, while procedures and services have grown at a rate of 2.7% in recent years. As a result, more patients are likely to choose biopsy procedures in ambulatory surgical centers, which will increase the demand for biopsy devices.
 

North America region accounted for more than 52% of the global biopsy devices market in 2022, primarily due to its well-established healthcare infrastructure. Additionally, the increasing prevalence of infectious diseases has resulted in the widespread acceptance of point-of-care diagnostic devices for early and safe disease detection. The region's advanced insurance and co-payment systems have also contributed to its dominance in the market. Furthermore, the presence of major industry players in the region is expected to drive the development and proliferation of biopsy equipment in North America.
 

Middle East and Africa biopsy devices market value is projected to surpass USD 110 million by 2032, driven by the introduction of government initiatives to support cancer patients. Additionally, several manufacturers and non-government organizations have adopted advanced technology to support healthcare service providers, thereby boosting the development of biopsy devices in the region.